Its important to stick to the dosing schedule and treatment plan your healthcare provider has given you
It is an FDA-approved appetite suppressant for people with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) with a weight-related health condition, and should be used alongside a balanced eating plan and exercise
Most weight changes are temporary, manageable, and reversible with a combination of early monitoring, lifestyle adjustments, and professional guidance
If you are receiving these drugs along with semaglutide, it is recommended to be mindful of potential symptoms, and if necessary, talk to your healthcare provider about other treatment options
Semaglutide targets the GLP-1 pathway, while tirzepatide activates both GLP-1 and GIP receptors, creating a dual-hormone effect that may influence blood sugar, satiety, and fat metabolism more comprehensively